P3 Health Partners Inc.
P3 Health Partners Inc. scores highest on Anchor (57) and lowest on Price (6). Its PosiPenta is 31.02 out of 100, weaker than most similar companies.
On the Penta Grid this week, P3 Health Partners Inc. is Grid #747 of 837 in the Healthcare sector in United States, and Grid #3,560 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| P3 Health Partners Inc. | 31.02 | 6 | 41 | 34 | 17 | 57 |
| Alumis Inc. | 31.51 | 31 | 29 | 26 | 42 | 30 |
| Corvus Pharmaceuticals, Inc. | 40.68 | 18 | 34 | 37 | 69 | 45 |
| Kura Oncology, Inc. | 35.23 | 4 | 32 | 61 | 25 | 54 |
| Verastem, Inc. | 38.26 | 4 | 42 | 83 | 9 | 53 |
| Rigel Pharmaceuticals, Inc. | 67.63 | 72 | 53 | 89 | 76 | 48 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.13 |
| P/B ratio | 11.69 |
EEarnings
| Trailing EPS | ₹-3127.49 |
| Forward EPS | ₹-19.89 |
NNitro
| Price | 392.12 |
| 52-week high | 1599.74 |
| 52-week low | 143.97 |
| Fall from 52-week high | 75.5% |
TTorque
| Return on equity (ROE) | -192.58% |
| Debt-to-equity | 0.95 |
AAnchor
| Beta (price swings) | 1.69 |
| Market cap | ₹7,990 Cr |
| Insider holding | 48.38% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is P3 Health Partners Inc.'s PosiPenta score?
P3 Health Partners Inc.'s PosiPenta is 31.02 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does P3 Health Partners Inc. stand on the Penta Grid?
On the Penta Grid this week, P3 Health Partners Inc. is Grid #747 of 837 in the Healthcare sector in United States, and Grid #3,560 of 4,000 in United States.
Which PosiPenta pillar is strongest for P3 Health Partners Inc.?
Anchor (stability and dividends), with a score of 57 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for P3 Health Partners Inc.?
Price (valuation), with a score of 6 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.